MediXall Group, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.DEF’

On:  Monday, 11/14/22, at 4:39pm ET   ·   For:  9/30/22   ·   Accession #:  1553350-22-902   ·   File #:  333-194337

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    628K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
11: R1          Cover                                               HTML     64K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    103K 
13: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     38K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     88K 
                (Unaudited)                                                      
15: R5          Consolidated Statements of Changes in               HTML     80K 
                Stockholders' Equity (Deficit) (Unaudited)                       
16: R6          Consolidated Statements of Changes in               HTML     17K 
                Stockholders' Equity (Deficit) (Unaudited)                       
                (Parenthetical)                                                  
17: R7          Condensed Consolidated Statements of Cash Flows     HTML     88K 
                (Unaudited)                                                      
18: R8          Organization and Nature of Operation                HTML     20K 
19: R9          Asset Acquisition                                   HTML     19K 
20: R10         Going Concern                                       HTML     21K 
21: R11         Summary of Significant Accounting Policies          HTML     69K 
22: R12         Right-to-use Intellectual Property                  HTML     30K 
23: R13         Preferred Stock                                     HTML     26K 
24: R14         Related Party Transactions                          HTML     34K 
25: R15         Senior Convertible Debentures and Warrants          HTML     31K 
26: R16         Summary of Significant Accounting Policies          HTML    102K 
                (Policies)                                                       
27: R17         Summary of Significant Accounting Policies          HTML     49K 
                (Tables)                                                         
28: R18         Right-to-use Intellectual Property (Tables)         HTML     30K 
29: R19         Related Party Transactions (Tables)                 HTML     26K 
30: R20         Senior Convertible Debentures and Warrants          HTML     25K 
                (Tables)                                                         
31: R21         Asset Acquisition (Details Narrative)               HTML     22K 
32: R22         Going Concern (Details Narrative)                   HTML     23K 
33: R23         Summary of Significant Accounting Policies          HTML     28K 
                (Schedule of Basic and Diluted EPS) (Details)                    
34: R24         Summary of Significant Accounting Policies          HTML     22K 
                (Schedule of potentially dilutive securities)                    
                (Details)                                                        
35: R25         Summary of Significant Accounting Policies          HTML     18K 
                (Details Narrative)                                              
36: R26         Right-to-use Intellectual Property (Schedule of     HTML     22K 
                Right-to-use Intellectual Property) (Details)                    
37: R27         Right-to-use Intellectual Property (Schedule of     HTML     30K 
                amortization expense for right-to-use intellectual               
                property) (Details)                                              
38: R28         Preferred Stock (Details Narrative)                 HTML     37K 
39: R29         Related Party Transactions (Details)                HTML     32K 
40: R30         Related Party Transactions (Details Narrative)      HTML     29K 
41: R31         Senior Convertible Debentures and Warrants          HTML     30K 
                (Details)                                                        
42: R32         Senior Convertible Debentures and Warrants          HTML     43K 
                (Details Narrative)                                              
45: XML         IDEA XML File -- Filing Summary                      XML     78K 
43: XML         XBRL Instance -- mdxl_10q_htm                        XML    646K 
44: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 7: EX-101.CAL  XBRL Calculations -- mdxl-20220930_cal               XML    107K 
 8: EX-101.DEF  XBRL Definitions -- mdxl-20220930_def                XML    226K 
 9: EX-101.LAB  XBRL Labels -- mdxl-20220930_lab                     XML    485K 
10: EX-101.PRE  XBRL Presentations -- mdxl-20220930_pre              XML    398K 
 6: EX-101.SCH  XBRL Schema -- mdxl-20220930                         XSD     87K 
46: JSON        XBRL Instance as JSON Data -- MetaLinks              204±   287K 
47: ZIP         XBRL Zipped Folder -- 0001553350-22-000902-xbrl      Zip    130K 

‘EX-101.DEF’   —   XBRL Definitions — mdxl-20220930_def

This Exhibit is an XBRL XML File.